Sertindole
Back to searchMolecule Structure
Scientific Name
Sertindole
Description of the Drug
Sertindole is an atypical antipsychotic indicated in the treatment of schizophrenia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06144
http://www.drugbank.ca/drugs/DB06144
Brand Name(s)
Serlect
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
| Adrenergic receptor alpha-1 | PROTEIN FAMILY | ANTAGONIST | CHEMBL2094251 |
| Serotonin 2 receptors; 5-HT2a & 5-HT2c | SELECTIVITY GROUP | ANTAGONIST | CHEMBL2096662 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL112092 |
| PharmGKB | PA164784002 |
| Human Metabolome Database | HMDB0015618 |
| DrugBank | DB06144 |
| PubChem: Thomson Pharma | 14905937 |
| PubChem | 60149 |
| LINCS | LSM-5765 |
| Nikkaji | J380.356B |
| BindingDB | 50001786 |
| EPA CompTox Dashboard | DTXSID6048967 |
| DrugCentral | 2435 |
| ChemicalBook | CB2221267 |
| Guide to Pharmacology | 98 |
| rxnorm | SERTINDOLE |
| PubChem: Drugs of the Future | 12014521 |
| KEGG Ligand | C07567 |
| ChEBI | 9122 |
| ZINC | ZINC000000538337 |
